Share on LinkedInShare on LinkedIn

ARTICLE · 16 JULY 2021

Show Your Work: FAQs On Non-Quantitative Treatment Limitation Comparative Analyses

Bryan Cave Leighton Paisner
Bryan Cave Leighton Paisner
Contributor
Bryan Cave Leighton Paisner

Bryan Cave Leighton Paisner

UK 2026 Chambers Firm Profile Bryan Cave Leighton Paisner (BCLP) is an international, fully...

View firm profile
Explore more from Bryan Cave Leighton Paisner

The Departments provided a list of practices and procedures which should be avoided in responding to requests from the Departments and state authorities.

United StatesEmployment and HR

Among the requirements under the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (the "MHPAEA") group health plans and health insurance issuers must apply any processes, strategies, evidentiary standards or other factors underlying non-quantitative treatment limitations ("NQTLs") to mental health or substance use disorder ("MH/SUD") benefits comparably and no more stringently than to medical/surgical benefits.

The Consolidated Appropriations Act, 2021 ("CAA") included provisions designed to enhance transparency with respect to compliance with the MHPAEA, including a requirement that group health plans and health insurance issuers perform and document comprehensive NQTL comparability analyses. We previously summarized the CAA's requirements in our Q1 2021 Newsletter, available by clicking here.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from